-
-
-
-
-
-
-
AstraZeneca contacted Gilead over potential megamerger: Bloomberg News
-
-
-
-
-
-
-
AbbVie to Present at the Jefferies 2017 London Healthcare Conference
-
-
-
-
-
-
-
AbbVie (ABBV): 135 IPR Hearing Shifted Odds Favourably - Jefferies
-
-
-
-
-
-
-
Notable Analyst Rating Changes 9/2: (TEVA) (PES) (AMFW) Upgraded; (STM) (NVO) (GCO) Downgraded
-
-
-
-
-
-
-
Gilead (GILD) Lags Other Biotechs Following HCV Data From Regulus (RGLS)
-
-
-
-
-
-
-
AbbVie to Present at Jefferies 2015 Healthcare Conference
-
-
-
-
-
-
-
Abbvie (ABBV) PT Lifted to $85 at Jefferies; Top Pick for 2015
-
72,046 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

